Literature DB >> 7945539

Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.

K M Jensen1, J B Dahl.   

Abstract

The plasma profiles of nitroglycerin (glyceryl trinitrate, GTN, CAS 55-63-0) and its dinitrate metabolites (1,2-GDN and 1,3-GDN) were estimated after sublingual administration of GTN tablets 0.5 mg (Nitromex) given in single doses to 20 volunteers. Blood samples (totally 20) were collected to 2 h after administration, and the plasma concentrations of GTN, 1,2-GDN, and 1,3-GDN were measured simultaneously by gas chromatography. The pharmacokinetic parameters, Cmax, tmax, t1/2, and the dinitrate ratio (AUC1,2-GDN/AUC1,3-GDN) were determined for each subject. The plasma concentrations of GTN reached a maximum of 1.38 ng/ml (mean) (range: 0.32-3.18 ng/ml) after 4.9 min (mean) (range: 3-8 min). The plasma concentrations of 1,2-GDN and 1,3-GDN reached a maximum of 3.11 ng/ml (mean) (range: 1.14-5.44 ng/ml) and 0.70 ng/ml (mean) (range: 0.33-1.19 ng/ml) after 13.7 min (mean) (range: 8-40 min) and 17.6 min (mean) (range: 8-40 min). The t1/2 values (mean) were 3.3, 35.5, and 38.1 min for GTN, 1,2-GDN, and 1,3-GDN, respectively. The dinitrate ratio was estimated to be 4.1 (mean).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945539

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  5 in total

1.  Drug enhancement of myocardial tracer uptake during myocardial perfusion imaging.

Authors:  Panagiotis Georgoulias; Varvara Valotassiou; Ioannis Tsougos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

2.  Constitutive nitric oxide synthase activation is a significant route for nitroglycerin-mediated vasodilation.

Authors:  Marcelo G Bonini; Krisztian Stadler; Sueli de Oliveira Silva; Jean Corbett; Michael Dore; John Petranka; Denise C Fernandes; Leonardo Y Tanaka; Danielle Duma; Francisco R M Laurindo; Ronald P Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

3.  Direct gas measurements indicate that the novel cyclooxygenase inhibitor AZD3582 is an effective nitric oxide donor in vivo.

Authors:  L Christofer Adding; Per Agvald; Lars I Andersson; Bror Jonzon; Janet Hoogstraate; Lars E Gustafsson
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

Review 4.  Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.

Authors:  Satoru Hashimoto; Atsuko Kobayashi
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 5.  Nitroglycerin for management of retained placenta.

Authors:  Hany Abdel-Aleem; Mahmoud A Abdel-Aleem; Omar M Shaaban
Journal:  Cochrane Database Syst Rev       Date:  2015-11-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.